US 8791244
Anti-ErbB3 antibodies and uses thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 8791244 (Anti-ErbB3 antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K31/517, A61K31/5377